Onkologia Erradioterapikoa
Espezialitatea
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaIkerbasque, Fundación Vasca para la Ciencia-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2022
2020
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
Scientific Reports, Vol. 10, Núm. 1
-
Oligometastatic prostate adenocarcinoma. Clinical-pathologic study of a histologically under-recognized prostate cancer
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-9
2018
-
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
Scientific Reports, Vol. 8, Núm. 1